Perikinetics ^Company

Perikinetics develops an artificial pancreas technology platform to deliver insulin physiologically. Its implant solution utilizes the superior kinetics of the intraperitoneal cavity that enable patients to manage diabetes efficiently. The company was founded in 2018 and is headquartered in San Francisco, California.